Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Clostridium difficile PCR-based test may gain quick adoption

July 26, 2009

Rapid DNA Test to Detect Clostridium difficile Infection Approved by FDA Today | www.medscape.com

 The FDA has approved a new assay which utilizes the GeneXpert platform and detects Toxin B DNA in less then an hour. The test is very sensitive and specific, and allows precise use of appropriate anti-C. diff. antibiotics early in care. 

Page : 11 to 1 of 1

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

This author consults with leading institutions through GLG